Revista Brasileira de Oftalmologia | |
Intravitreal ranibizumab as adjuvant treatment for neovascular glaucoma | |
Flavia Gazze Ticly1  Rodrigo Pessoa Cavalcanti Lira1  Enzo Augusto Medeiros Fulco1  José Paulo Cabral De Vasconcelos1  | |
[1] ,Universidade Estadual de Campinas Department of Ophthalmology Campinas SP ,Brasil | |
关键词: Neovascular; glaucoma; Chemotherapy; adjuvante; Intraocular pressure; Intravitreal injections; Antibodies; monoclonal; Case reports; Glaucoma neovascular; Quimioterapia adjuvante; Pressão intraocular; Injeções intravítreas; Anticorpos monoclonais; Relatos de casos; | |
DOI : 10.1590/S0034-72802013000200010 | |
来源: SciELO | |
【 摘 要 】
The purpose of this study was to describe a prospective case series of 5 eyes treated with intravitreal ranibizumab injection for neovascular glaucoma (NVG). Five patients with clinically uncontrolled NVG secondary to proliferative diabetic retinopathy (4 patients) and central retinal vein occlusion (1 patient), non-responsive to maximal tolerable medication and panretinal photocoagulation, received intravitreal ranibizumab injection (0.5 mg). Patients were seen at 1st, 3rd and 7th day after the ranibizumab injection and when it was necessary. Success was defined as intraocular pressure (IOP)
【 授权许可】
CC BY
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202103040022786ZK.pdf | 679KB | download |